πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 2,465 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 10201596

Peptide conjugated particles for the treatment of allergy

Northwestern University Β· Granted Tue Feb 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10202412

Ξ²-D-2β€²-deoxy-2β€²-substituted-4β€²-substituted-2-substituted-N6-substituted-6-aminopurinenucle

Atea Pharmaceuticals, Inc. Β· Granted Tue Feb 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10201547

Method of treatment of aggression

Supernus Pharmaceuticals, Inc. Β· Granted Tue Feb 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10202449

Cachexia treatment

XBIOTECH INC. Β· Granted Tue Feb 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10196443

TEM8 antibodies and their use in treatment and detection of tumors

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Feb 05 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10195168

Gamma-hydroxybutyrate compositions and their uses for the treatment of disorders

Jazz Pharmaceuticals Ireland Limited Β· Granted Tue Feb 05 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10195259

Compositions and methods for treatment of cancer using bacteria

Decoy Biosystems, Inc. Β· Granted Tue Feb 05 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10188635

Use of gaboxadol in the treatment of tinnitus

OVID THERAPEUTICS INC. Β· Granted Tue Jan 29 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10188650

Treatment of neurological disorders

THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Tue Jan 29 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10188656

Methods of treatment of malignancies

Agios Pharmaceuticals, Inc. Β· Granted Tue Jan 29 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10184004

CD47 targeted therapies for the treatment of infectious disease

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jan 22 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10183942

JAK kinase inhibitor compounds for treatment of respiratory disease

Theravance Biopharma R&D IP, LLC Β· Granted Tue Jan 22 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10182997

Liposomal curcumin for treatment of cancer

The Board of Regents of the University of Texas System Β· Granted Tue Jan 22 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10183055

Ang-(1-7) derivative oligopeptides for the treatment of pain and other indications

Arizona Board of Regents on Behalf of the University of Arizona Β· Granted Tue Jan 22 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10179912

RNA modulating oligonucleotides with improved characteristics for the treatment of duchenn

BIOMARIN TECHNOLOGIES B.V. Β· Granted Tue Jan 15 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 10 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10179119

Method of treatment

VANDA PHARMACEUTICALS INC. Β· Granted Tue Jan 15 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 10 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10179142

Treatment and/or prevention of bone metastasis

Arizona Board of Regents on Behalf of the University of Arizona Β· Granted Tue Jan 15 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 10 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10172937

Method of treatment of malignant solid tumors with afucosylated anti-FGFR2IIIb antibodies

Five Prime Therapeutics, Inc. Β· Granted Tue Jan 08 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10173074

Cancer stem cell vaccination and treatment

THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Tue Jan 08 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10172920

Sleep apnea treatment

THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Tue Jan 08 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10167334

Treatment of cancer using anti-TGF-BETA and PD-1 antibodies

The Regents of the University of California Β· Granted Tue Jan 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10167337

Combination immunotherapy for the treatment of cancer

The Board of Regents of the University of Texas System Β· Granted Tue Jan 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10167263

Treatment of amyotrophic lateral sclerosis

Northwestern University Β· Granted Tue Jan 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10154974

Use of abscisic acid for the prevention and treatment of malaria

The Regents of the University of California Β· Granted Tue Dec 18 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted